Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07545486Not Yet Recruiting

Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment

Role: lead

NCT07332910Phase 4Not Yet Recruiting

Study the Anti-inflammatory Effect of Tranexamic Acid When Used in Anterior Cruciate Ligament Reconstruction.

Role: lead

NCT07064317Completed

Catheter Tip Position and Contrast Distribution Following Paravertebral Catheter Insertion: a CT Study

Role: collaborator

NCT06792292Not ApplicableNot Yet Recruiting

Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital

Role: lead

NCT06601868Phase 4Not Yet Recruiting

The Impact of Nutritional Optimization to Enhance Postoperative Outcomes Using the R-Support Supplements

Role: collaborator

NCT04366921Unknown

European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO

Role: collaborator

All 6 trials loaded